Trinity Biotech Plc Stock Filter Stocks by Fundamentals
| TRIB Stock | USD 0.67 0.01 1.52% |
Trinity Biotech plc fundamentals help investors to digest information that contributes to Trinity Biotech's financial success or failures. It also enables traders to predict the movement of Trinity Stock. The fundamental analysis module provides a way to measure Trinity Biotech's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Trinity Biotech stock.
Trinity | Shares Owned by Insiders |
Trinity Biotech Institutional Holders
Institutional Holdings refers to the ownership stake in Trinity Biotech that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Trinity Biotech's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Trinity Biotech's value.| Shares | Integrys Wealth Advisors Llc | 2024-12-31 | 10 K | Hartland & Co | 2024-12-31 | 10 K | Morgan Stanley - Brokerage Accounts | 2024-12-31 | 2.2 K | Rhumbline Advisers | 2024-12-31 | 1.8 K | Simplex Trading, Llc | 2024-12-31 | 1.4 K | Jones Financial Companies Lllp | 2024-12-31 | 468 | Bank Of America Corp | 2024-12-31 | 240 | Atlantic Trust Group, Llc | 2024-12-31 | 222 | Atwood & Palmer Inc | 2024-12-31 | 20.0 | Perceptive Advisors Llc | 2024-12-31 | 1.8 M | Hunter Associates Inc. | 2024-12-31 | 378.6 K |
Trinity Fundamentals
| Return On Equity | -19.13 | ||||
| Return On Asset | -0.0819 | ||||
| Profit Margin | (0.34) % | ||||
| Operating Margin | (0.15) % | ||||
| Current Valuation | 109.41 M | ||||
| Shares Outstanding | 27.52 M | ||||
| Shares Owned By Insiders | 12.39 % | ||||
| Shares Owned By Institutions | 14.60 % | ||||
| Number Of Shares Shorted | 396.91 K | ||||
| Price To Earning | 31.00 X | ||||
| Price To Book | 5.11 X | ||||
| Price To Sales | 0.31 X | ||||
| Revenue | 56.83 M | ||||
| Gross Profit | 21.13 M | ||||
| EBITDA | (24.1 M) | ||||
| Net Income | (24.02 M) | ||||
| Cash And Equivalents | 10.01 M | ||||
| Cash Per Share | 0.41 X | ||||
| Total Debt | 67.43 M | ||||
| Current Ratio | 3.66 X | ||||
| Book Value Per Share | (2.54) X | ||||
| Cash Flow From Operations | (11.56 M) | ||||
| Short Ratio | 0.03 X | ||||
| Earnings Per Share | (2.25) X | ||||
| Price To Earnings To Growth | 1.30 X | ||||
| Target Price | 3.0 | ||||
| Number Of Employees | 380 | ||||
| Beta | 1.21 | ||||
| Market Capitalization | 18.53 M | ||||
| Total Asset | 59.44 M | ||||
| Retained Earnings | (48.64 M) | ||||
| Working Capital | 24.01 M | ||||
| Current Asset | 151 M | ||||
| Current Liabilities | 21 M | ||||
| Net Asset | 59.44 M |
About Trinity Biotech Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Trinity Biotech plc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Trinity Biotech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Trinity Biotech plc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| ZLAB | Zai Lab | |
| ASLE | AerSale Corp | |
| ATS | AT S Austria |
Check out Trinity Biotech Piotroski F Score and Trinity Biotech Altman Z Score analysis. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Trinity Biotech. If investors know Trinity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Trinity Biotech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.77) | Earnings Share (2.25) | Revenue Per Share | Quarterly Revenue Growth 0.032 | Return On Assets |
The market value of Trinity Biotech plc is measured differently than its book value, which is the value of Trinity that is recorded on the company's balance sheet. Investors also form their own opinion of Trinity Biotech's value that differs from its market value or its book value, called intrinsic value, which is Trinity Biotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Trinity Biotech's market value can be influenced by many factors that don't directly affect Trinity Biotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Trinity Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if Trinity Biotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Trinity Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.